4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzoic acid, 97%, 100mg

4-Methylumbelliferyl-N-acetyl-β-D-galactosaminide, 500 mg

Filtration unit with SFCA membrane Pore size 0.45 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

3-(4-Methylpiperazin-1-yl)aniline, 95.0%, 10g

N-Benzyl-4-methoxyaniline, 97%, 25g

1-(3,4-Dichlorophenyl)-2,2-difluoroethanone, 97.0%, 100mg

3-Nitro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

6-Chloroindolizine-2-carboxylic acid, 98%, 5g

2-(TETRAHYDRO-2H-PYRAN-4-YL)ETHYL 4-METHYLBENZENESULFONATE, 95.0%, 25g

Methyl 1,4-dihydroxy-2-naphthoate, 95.0%, 100g

2-(Perfluorohexyl)ethyl acrylate, 97.0%, 5g

2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 25g

3-cyclopropyl-4-methyl-4H-1,2,4-triazole hydrochloride, 95.0%, 25g